Analyzing LENSAR (NASDAQ:LNSR) & Precision Optics (NASDAQ:POCI)

LENSAR (NASDAQ:LNSR – Get Free Report) and Precision Optics (NASDAQ:POCI – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and price targets for LENSAR and Precision Optics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR 1 0 2 0 2.33
Precision Optics 1 0 0 0 1.00

LENSAR currently has a consensus target price of $11.00, indicating a potential upside of 126.80%. Given LENSAR’s stronger consensus rating and higher possible upside, equities research analysts clearly believe LENSAR is more favorable than Precision Optics.

Profitability

This table compares LENSAR and Precision Optics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LENSAR 56.07% 1,254.25% 49.13%
Precision Optics -7.48% -14.87% -8.33%

Valuation and Earnings

This table compares LENSAR and Precision Optics”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
LENSAR $60.08 million 0.99 -$34.28 million ($0.40) -12.12
Precision Optics $31.53 million 1.46 -$3.63 million ($0.46) -9.09

Precision Optics has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Precision Optics, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

LENSAR has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500.

Insider and Institutional Ownership

40.2% of LENSAR shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 65.8% of LENSAR shares are held by company insiders. Comparatively, 12.7% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

LENSAR beats Precision Optics on 12 of the 14 factors compared between the two stocks.

About LENSAR

(Get Free Report)

LENSAR, Inc. develops and markets laser-based technology for ophthalmic surgery, with a focus on procedures used to treat cataracts. Its systems are designed to assist surgeons with key steps in cataract surgery, including the creation of incisions and the fragmentation of the eye’s natural lens. The company’s products include the ALLY Adaptive Cataract Treatment System and the LENSAR Laser System, which use imaging and software to support surgical planning and treatment. LENSAR also offers related software, accessories and services for ophthalmic practices and surgical facilities.

About Precision Optics

(Get Free Report)

Precision Optics Corporation, Inc. designs and manufactures optical systems and components for medical, defense, aerospace and industrial applications. Its work spans product development, prototyping, engineering and production for customers seeking specialized imaging solutions. The company’s products include rigid and flexible endoscopes, three-dimensional endoscopic imaging systems, micro-optics and other precision optical assemblies. Its offerings support medical-device makers and other organizations that need compact, high-performance imaging equipment.

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.